TXG Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - 10X Genomics Inc

Watchlist Manager

Watchlist

Price: 39.01 USD -0.1% Market Closed

Market Cap: $5B

	10X Genomics Inc NASDAQ:TXG	US
	Covivio SA F:F5D	FR
	Perimeter Solutions SA NYSE:PRM	LU

Profitability Summary

10X Genomics Inc's profitability score is 36/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

68%

Declining Gross Margin

74% > 70%

Negative Operating Margin

-11%

Negative 3Y Average Operating Margin

-28%

Operating Margin is Increasing

-31% > -11%

Negative Net Margin

-4%

Negative 3Y Average Net Margin

-26%

Net Margin is Increasing

-30% > -4%

Exceptional Free Cash Flow Margin

20%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-21% > 20%

Negative ROE

-3%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-34%

ROIC is Increasing

-35% > -17%

View All

Hide

Collapse

36 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.